Infections with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map?
- PMID: 10886543
- DOI: 10.1046/j.1365-2893.2000.00222.x
Infections with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map?
Abstract
We studied prospectively, between 1993 and 1998, the prevalence and incidence of markers against hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis D virus (HDV), in 180 patients with chronic renal failure, dialysed in the Nephrological Clinic, Cluj. HBV and HCV markers were common in the patients who were already on haemodialysis in 1993 (antibodies to hepatitis B core antigen [HBcAb]: 57.9-88%; hepatitis B surface antigen [HBsAg]: 8.7-25%; antibodies to HCV [anti-HCV]: 73.7-100%; simultaneous occurrence of HBsAg and anti-HCV antibodies: 4.4-21%). These patients had the longest mean duration of haemodialysis therapy (6.79 +/- 4.82 years). The lowest prevalence was found in 1996, in the groups of patients included in the haemodialysis programme between 1993 and 1996 (HBcAb: 2.2-3.3%; HBsAg: 0-2.2%; anti-HCV antibodies: 0-2.2%; HBsAg and anti-HCV antibodies: 0-2.2%). The patients included since 1996 had, again, a high prevalence of markers (HBsAg: 21.6%; anti-HCV antibodies: 28.6%), despite the short duration of dialysis therapy (1.65 +/- 1.18 years). The incidence of infection was high before 1993, fell markedly between 1993 and 1996 (zero for the HBsAg and 6. 67% year-1 for the anti-HCV antibodies) and rose sharply between 1996 and 1998 (10.2%, respectively 29% year-1). The prevalence of HBV and HCV infections did not correlate with the age of the patients and depended, but only up to 1993, on the quantity of transfused blood. The link between the duration of the haemodialysis and the prevalence of the HBV and/or HCV infection proved nosocomial transmission. The very high prevalence and incidence of HBV and HCV infections, surpassing not only Western countries, but even those of 'developing' countries that are endemic for these infections, is characteristic of some former communist countries. A radical reform of the medical system in these countries is required.
Similar articles
-
Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients.J Egypt Public Health Assoc. 1995;70(5-6):465-84. J Egypt Public Health Assoc. 1995. PMID: 17214170
-
Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors.BMC Infect Dis. 2012 Oct 20;12:265. doi: 10.1186/1471-2334-12-265. BMC Infect Dis. 2012. PMID: 23082935 Free PMC article.
-
A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania.J Gastrointestin Liver Dis. 2010 Mar;19(1):43-8. doi: 10.1007/s11749-009-0177-3. J Gastrointestin Liver Dis. 2010. PMID: 20361074
-
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.Lancet. 2011 Aug 13;378(9791):571-83. doi: 10.1016/S0140-6736(11)61097-0. Epub 2011 Jul 27. Lancet. 2011. PMID: 21802134 Free PMC article. Review.
-
Review article: Hepatitis B and dialysis.Nephrology (Carlton). 2010 Mar;15(2):137-45. doi: 10.1111/j.1440-1797.2009.01268.x. Nephrology (Carlton). 2010. PMID: 20470270 Review.
Cited by
-
Improving hepatitis B vaccine efficacy in end-stage renal diseases patients and role of adjuvants.ISRN Gastroenterol. 2012;2012:960413. doi: 10.5402/2012/960413. Epub 2012 Sep 18. ISRN Gastroenterol. 2012. PMID: 23029621 Free PMC article.
-
Hepatitis Viruses B and D and Human Immunodeficiency Virus Infections in Hemodialysis Patients in the South of Iran: Prevalence and Genotypes.Hepat Mon. 2016 Jan 23;16(1):e32971. doi: 10.5812/hepatmon.32971. eCollection 2016 Jan. Hepat Mon. 2016. PMID: 27110260 Free PMC article.
-
Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units.Cochrane Database Syst Rev. 2016 Aug 11;2016(8):CD006420. doi: 10.1002/14651858.CD006420.pub2. Cochrane Database Syst Rev. 2016. PMID: 27513591 Free PMC article.
-
Risk factors associated with nosocomial infections among end stage renal disease patients undergoing hemodialysis: A systematic review.PLoS One. 2020 Jun 22;15(6):e0234376. doi: 10.1371/journal.pone.0234376. eCollection 2020. PLoS One. 2020. PMID: 32569265 Free PMC article.
-
A shield against a monster: Hepatitis C in hemodialysis patients.World J Gastroenterol. 2009 Feb 14;15(6):641-6. doi: 10.3748/wjg.15.641. World J Gastroenterol. 2009. PMID: 19222088 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical